Atlas Trials

A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Clinical trial NCT03561701 · COMPLETED

Trial details

NCT number
NCT03561701
Sponsor
Mycovia Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Vulvovaginal Candidiasis
Start date
2018-08-23
Primary completion
2020-10-13
Enrollment
425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.